FDA clears Endosonics' Oracle-Micro catheter

Article

Intraluminal ultrasounddeveloper Endosonics announced this month that the Food and DrugAdministration has cleared its Oracle-Micro catheter, which combinescoronary balloon angioplasty with ultrasound imaging. Endosonicsclaims that the product is the only

Intraluminal ultrasounddeveloper Endosonics announced this month that the Food and DrugAdministration has cleared its Oracle-Micro catheter, which combinescoronary balloon angioplasty with ultrasound imaging. Endosonicsclaims that the product is the only device that can perform bothpercutaneous transluminal coronary angioplasty (PTCA) and intravascularultrasound on the same catheter.

In clinical studies the company submitted to the FDA, cardiologistsusing Oracle-Micro had different impressions of treatment successand in some cases changed therapy decisions compared to cardiologistswho used conventional angiographic imaging.

Gaining FDA approval for Oracle-Micro was not a cake walk,however. The agency earlier this year asked Endosonics to revisethe data in the application (SCAN 8/31/94). Endosonics won theagency's go-ahead within weeks of resubmitting the application,the company reported.

Endosonics plans limited shipments of the current version ofOracle-Micro to U.S. customers while it submits a series of PMAsupplements for the latest version of the product.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.